(c) 2024 PillSync.com

soma carisoprodol tablet film coated

1 INDICATIONS AND USAGE Carisoprodol tablets, USP is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration ( 2 ) ]. CARISOPRODOL Tablets, USP is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. ( 1 ) Limitations of Use: Should only be used for acute treatment periods up to two or three weeks ( 1 )

carlsbad technology, inc.


4 years ago ROUND WHITE SG 109 soma carisoprodol tablet film coated

ROUND WHITE SG 109

4 years ago ROUND WHITE SG 109 soma carisoprodol tablet film coated

SG 109 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Carisoprodol Tablets, USP 350 mg: round, biconvex, white tablets, debossed with OP 35 on one side; available in bottles of 100 (NDC 61442-451-01), available in bottles of 500 (NDC 61442-451-05), available in bottles of 1000 (NDC 61442-451-10). Storage: Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].


More pills like ROUND SG 109

Related Pills

soma carisoprodol tablet film coated

carlsbad technology, inc.

CARISOPRODOL Carisoprodol 350 MG Oral Tablet

Vensun Pharmaceuticals, Inc.

CARISOPRODOL Carisoprodol 350 MG Oral Tablet

Vensun Pharmaceuticals, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site